NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Provides Update on Progression of CBD Patents, Reacts to DEA’s Shifted Stance toward CBD

October 3, 2018 09:32:33

Biotechnology company Earth Science Tech Inc. (OTCQB: ETST) this morning issued an update on the progression of its cannabidiol patents, as well as its reaction to the U.S. Drug Enforcement Agency’s recent decision to remove certain CBD products from its Schedule 1 list of controlled substances. Per the update and as previously announced, ETST intends to launch two CBD-based nutraceutical formulas – a neuron protector and a breast protector – under a provisory patent. The company noted that the Quebec Agrifood Innovation Center is finishing the standardization of the formulas and, by the end of October, TransBiotech is expected to conduct in vitro testing for the formulas’ biological activities. “The results obtained from TransBiotech will help us understand the mechanism of action of CBD and will open the doors for the research needed to develop revolutionary CDB-based pharmaceutical drugs,” Nickolas Tabraue, president and CEO of ETST, stated in the news release.

ETST CEO and Chief Science Officer Dr. Michel Aubé spoke to the recent changes implemented by the DEA. “In 2018, we have a much deeper understanding of cannabinoids, cannabinoid-receptors, and the endocannabinoid system than we did decades ago when CBD was classified as a schedule 1 drug,” he noted. “We are pleased to see that the DEA has shifted its stance amid conclusive evidence that CBD is not addictive but has both anti-psychotic properties and the opposite effect of THC.”

To view the full press release, visit

About Earth Science Tech, Inc.

Earth Science Tech, Inc. offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma; in addition to studies through DV Biologics that prove the Company’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market. For more information, visit the company’s website at

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office